| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/23/2000 | EP1029551A2 Nitrogen monoxide metabolite-polyoxyalkylene-hemoglobin complex |
| 08/23/2000 | EP1029550A1 Preventives and remedies for diffuse lung diseases |
| 08/23/2000 | EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 08/23/2000 | EP1029547A1 Pharmaceutically active compounds and method for identifying same |
| 08/23/2000 | EP1029546A1 Heparin cofactor ii preparations and process for producing the same |
| 08/23/2000 | EP1029538A2 Soft gelatin capsule manufacture |
| 08/23/2000 | EP1029536A1 Buccal non-polar spray |
| 08/23/2000 | EP1029456A1 Foods for preventing vomiting |
| 08/23/2000 | EP1029080A1 Human blood bacterium |
| 08/23/2000 | EP1029070A1 Transfecting peptide vector, composition containing same and applications |
| 08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 08/23/2000 | EP1029061A2 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
| 08/23/2000 | EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 08/23/2000 | EP1029057A1 Reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
| 08/23/2000 | EP1029055A2 Essential fungal genes and their use |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029053A1 Nucleic acid fragments and polypeptide fragments derived from mycobacterium tuberculosis |
| 08/23/2000 | EP1029052A2 Neisserial antigens |
| 08/23/2000 | EP1029051A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
| 08/23/2000 | EP1029050A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029048A2 Sequences for targeting metastatic cells |
| 08/23/2000 | EP1029047A2 Conductine protein and a related agent for diagnosing and treating tumor illnesses |
| 08/23/2000 | EP1029044A1 Tissue cement proteins from rhipicephalus appendiculatus |
| 08/23/2000 | EP1029043A1 Human receptor proteins; related reagents and methods |
| 08/23/2000 | EP1029035A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
| 08/23/2000 | EP1029033A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES) |
| 08/23/2000 | EP1028991A1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/23/2000 | EP1028977A2 Bifidus stimulating peptides |
| 08/23/2000 | EP1028975A1 Artemin, a novel neurotrophic factor |
| 08/23/2000 | EP1028974A1 Secreted proteins and polynucleotides encoding them |
| 08/23/2000 | EP1028973A1 IgG-BINDING PROTEIN FROM $i(STAPHYLOCOCCUS) AND NUCLEOTIDE SEQUENCE ENCODING THIS PROTEIN |
| 08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/23/2000 | EP1028942A2 Dipeptide nitriles |
| 08/23/2000 | EP1028774A1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 08/23/2000 | EP1028752A2 Platelet substitutes and conjugation methods suitable for their preparation |
| 08/23/2000 | EP1028751A1 Methods and compositions comprising glycoprotein glycoforms |
| 08/23/2000 | EP1028749A1 Enterococcus antigens and vaccines |
| 08/23/2000 | EP1028748A1 Compositions providing for increased igf-i solubility |
| 08/23/2000 | EP1028747A1 Novel igf-i composition and its use |
| 08/23/2000 | EP1028746A1 Method for producing igf-i sustained-release formulations |
| 08/23/2000 | EP1028745A1 Interferon immunotherapy |
| 08/23/2000 | EP1028744A2 Neuronal uses of bmp-11 |
| 08/23/2000 | EP1028743A1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGF$g(b) OR ACTIVIN |
| 08/23/2000 | EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 08/23/2000 | EP1028741A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/23/2000 | EP1028740A1 Enhanced opening of abnormal brain tissue capillaries |
| 08/23/2000 | EP1028739A2 Use of protein h as cytostatic agent |
| 08/23/2000 | EP1028738A1 Use of cytokines and mitogens to inhibit pathological immune responses |
| 08/23/2000 | EP1028737A1 Human mesenchymal stem cells from peripheral blood |
| 08/23/2000 | EP1028735A1 Therapeutic methods comprising use of a neuregulin |
| 08/23/2000 | EP1028730A1 Compositions of lipid lowering agents |
| 08/23/2000 | EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/23/2000 | EP1028727A1 Skin penetration enhancing components |
| 08/23/2000 | EP1028725A1 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 08/23/2000 | EP1028716A1 Method for treating and preventing heart failure and ventricular dilatation |
| 08/23/2000 | EP1028715A1 Dosage composition for nasal delivery and method of use of the same |
| 08/23/2000 | EP1028706A1 Buffered drug formulations for transdermal electrotransport delivery |
| 08/23/2000 | EP1028626A1 Method for the augmentation of gene expression |
| 08/23/2000 | EP0866799A4 Apolipoprotein e2 and treatment of alzheimer's disease |
| 08/23/2000 | EP0861228B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 08/23/2000 | EP0674506B1 Controlled release growth hormone containing microspheres |
| 08/23/2000 | EP0667859B1 Molecule labelling using 2-hydraninopyridine derivatives |
| 08/23/2000 | EP0584247B1 Compositons for the treatment of chronic fatigue syndrome |
| 08/23/2000 | CN1264427A Osteoprotegernin binding proteins and receptors |
| 08/23/2000 | CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
| 08/23/2000 | CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 08/23/2000 | CN1264388A Dolastatin 15 derivatives |
| 08/23/2000 | CN1264307A Method of enhancing function of upper gastrointestinal tract |
| 08/23/2000 | CN1264306A Method for treatment of diarrhea disease and removing special bacterial population |
| 08/23/2000 | CN1264305A Oral care composition comprising bacillus pullulanase and dextranase |
| 08/23/2000 | CN1263778A Thrombolytic medicine |
| 08/23/2000 | CN1055701C Piptide capable of inducing immune response against HIV and edicine for AIDS preventive and remedy containing the peptide |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/23/2000 | CN1055699C Sulfomycin analogue |
| 08/23/2000 | CN1055698C Tripeptide antithrombotic agents |
| 08/23/2000 | CN1055697C Phospholipi derivatives containing higher elements of the Vth main group |
| 08/23/2000 | CN1055641C Method of enhancing mental function |
| 08/23/2000 | CN1055640C Human calcium degrading gene concerned peptide fatty composite and preparation thereof |
| 08/23/2000 | CN1055618C Method for preparing prolonged release microcapsules |
| 08/22/2000 | US6107541 PRAD1 transgenic mice |
| 08/22/2000 | US6107499 Dopamine analog amide |
| 08/22/2000 | US6107476 Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth |
| 08/22/2000 | US6107475 Seven transmembrane receptors |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6107472 Receptor-type tyrosine kinase-like molecules |
| 08/22/2000 | US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody |
| 08/22/2000 | US6107467 Process for purifying a compound |
| 08/22/2000 | US6107465 Interleukin-1 beta mutants with defined amino acid sequences; have reduced side effects or toxicity; antiradiation agents; antiinflammatory/antiarthritic agents; immune system stimulants |
| 08/22/2000 | US6107464 iceA gene and related methods |
| 08/22/2000 | US6107462 Amino acid sequences of 3-hydroxy-3-methylglutaryl-coenzyme a reductase degradation polypeptides; for screening drugs |
| 08/22/2000 | US6107461 Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
| 08/22/2000 | US6107460 Analogs derived from the native sequences of cationic antimicrobial protein of molecular weight 37 kilodaltons from amino acids 20-44 and 23-42; bactericides for prophylaxis and treatment of septic shock |
| 08/22/2000 | US6107458 Cyclic hexapeptides having antibiotic activity |
| 08/22/2000 | US6107457 Bcr-abl peptide having tyrosine from position 177 and/or tyrosine from position 283; suppresses induction of ras protein; anticarcinogenic agents for leukemia; enriching bone marrow stem cells prior to transplantation |
| 08/22/2000 | US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity |
| 08/22/2000 | US6107306 Heterocyclic compounds |
| 08/22/2000 | US6107293 Analgesics |
| 08/22/2000 | US6107289 Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
| 08/22/2000 | US6107287 Killing tumor cells |